Successful treatment of relapsed acute promyelocytic leukemia with arsenic trioxide in a hemodialysis-dependent patient: A case report

BACKGROUND: Arsenic trioxide (ATO) is recommended for patients who do not achieve molecular remission or who have molecular or morphologic relapse. However, there are no guidelines for adjusting ATO dosage in patients with severe renal failure or on dialysis. Herein, we report the successful treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hee Jeong, Park, Sang-Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674717/
https://www.ncbi.nlm.nih.gov/pubmed/33269269
http://dx.doi.org/10.12998/wjcc.v8.i21.5347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674717/
https://www.ncbi.nlm.nih.gov/pubmed/33269269
http://dx.doi.org/10.12998/wjcc.v8.i21.5347

Ejemplares similares